Medication-Related Post-COVID-19 Osteonecrosis of the Jaw: An Interprofessional Approach to Prevention, Diagnosis, and Management.
Saudi Journal of Medicine and Public Health · 15.11.2026 · 3 (1) · 417-430
DOI: 10.64483/202631837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Journal of Medicine and Public Health, online erschienen am 15.11.2026. Verfasst von Abdulaziz Hadi Ibrahim Tawhari und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Post-COVID-19 osteonecrosis of the jaw (PC-ONJ) has emerged as an uncommon but clinically significant complication reported after SARS-CoV-2 infection. Its development may involve multiple interacting factors, including corticosteroid exposure, diabetes mellitus, immunosuppression, vascular injury, and secondary infections. COVID-associated mucormycosis (CAM) represents a particularly aggressive form that can cause extensive maxillofacial destruction and life-threatening complications.
Aim
This review examines the clinical presentation, risk factors, diagnostic challenges, and current management strategies for PC-ONJ, with particular attention to differentiating non-fungal osteonecrotic lesions from CAM.
Methods
A narrative review of the relevant literature was conducted to summarize reported clinical manifestations, proposed pathogenic mechanisms, diagnostic approaches, treatment options, and outcomes. Evidence concerning medical and surgical interventions, adjunctive therapies, and preventive measures was also considered.
Results
PC-ONJ presents with variable manifestations, including persistent facial pain, swelling, tooth mobility, exposed bone, fistulas, and delayed wound healing. The maxilla is frequently affected, and lesions may extend into the paranasal sinuses and adjacent structures. Diagnosis remains challenging because clinical and radiological findings overlap with osteomyelitis, medication-related osteonecrosis, osteoradionecrosis, malignancy, and invasive fungal infections. Management depends on the underlying pathology and disease extent. CAM requires prompt systemic antifungal therapy and surgical debridement, whereas non-fungal lesions may respond to conservative measures, antibiotics when indicated, and appropriate surgery.
Conclusion
Early recognition, accurate etiological assessment, metabolic control, and multidisciplinary management are essential to improve outcomes and reduce complications.
Zitieren
APA
Tawhari, A. H. I., Alotaibi, S. A., Mobarki, I. A. N., Alotaibi, M. A., Alrashidi, A. M. K., Almalki, A. M., Alhafi, M. R. M., Hadadi, F. A., Alanazi, E. K., Mubarak, S. K., Ageeli, A. A. J., Alotaibi, S. D. F., & Albusairi, W. A. (2026). Medication-Related Post-COVID-19 Osteonecrosis of the Jaw: An Interprofessional Approach to Prevention, Diagnosis, and Management. Saudi Journal of Medicine and Public Health, 3(1), 417-430. https://doi.org/10.64483/202631837
Vancouver
Tawhari AHI, Alotaibi SA, Mobarki IAN, Alotaibi MA, Alrashidi AMK, Almalki AM, et al. Medication-Related Post-COVID-19 Osteonecrosis of the Jaw: An Interprofessional Approach to Prevention, Diagnosis, and Management. Saudi Journal of Medicine and Public Health. 2026;3(1):417-430. doi:10.64483/202631837
BibTeX
@article{Tawhari2026,
author = {Tawhari, Abdulaziz Hadi Ibrahim and Alotaibi, Salman Abdulrahman and Mobarki, Ibrahim Abdullah Nasser and Alotaibi, Muneera Abdulrhman and Alrashidi, Ahmed Muslih Khlaif and Almalki, Ahlam Mohammad and Alhafi, Mutlaq Rahim Mutlaq and Hadadi, Faizah Ali and Alanazi, Elham Kamil and Mubarak, Sitah Khairallah and Ageeli, Awatif Ali Jurbuh and Alotaibi, Samiyah Dhaifallah Fahad and Albusairi, Waleed Abdullah},
title = {Medication-Related Post-COVID-19 Osteonecrosis of the Jaw: An Interprofessional Approach to Prevention, Diagnosis, and Management},
journal = {Saudi Journal of Medicine and Public Health},
year = {2026},
volume = {3},
number = {1},
pages = {417--430},
doi = {10.64483/202631837}
}
EUVIMED